Updated: January 15, 2026
Why Is Isosorbide So Hard to Find? [Explained for 2026]
Author
Peter Daggett

Summarize with AI
- What Is Isosorbide and Who Takes It?
- Why Does Isosorbide Go Out of Stock?
- Is There an Official FDA Shortage for Isosorbide in 2026?
- Which Forms of Isosorbide Are Most Affected?
- What Should You Do if Your Pharmacy Is Out of Isosorbide?
- Why Calling Pharmacies Is So Difficult (and How to Make It Easier)
- How Long Does an Isosorbide Shortage Last?
- Are There Alternatives to Isosorbide If I Can't Get It?
- Bottom Line
Isosorbide shortages are frustrating heart patients across the U.S. Here's why pharmacies run out, who is most affected, and what you can do right now.
If you take isosorbide mononitrate or isosorbide dinitrate for angina, you may have noticed that your pharmacy doesn't always have it ready and waiting. Across the United States in 2026, patients with coronary artery disease are running into empty shelves, delayed refills, and confused pharmacy staff — all because of a drug that has been around for decades.
This guide explains why isosorbide can be difficult to find, who is most affected, and what practical steps you can take when your pharmacy is out of stock.
What Is Isosorbide and Who Takes It?
Isosorbide is a nitrate medication used to prevent chest pain (angina) caused by coronary artery disease. It comes in two main forms: isosorbide mononitrate (brand names Imdur, Monoket, ISMO) and isosorbide dinitrate (brand names Isordil, Dilatrate-SR). Both work by relaxing and widening blood vessels, which reduces the heart's workload and prevents angina attacks.
Millions of Americans rely on this drug daily. Because it is taken on a fixed schedule — often once or twice a day — running out even for a few days can put a patient at serious risk of breakthrough angina. That makes any supply disruption a genuine medical concern, not just a minor inconvenience.
Why Does Isosorbide Go Out of Stock?
Several factors contribute to isosorbide availability problems:
- Generic market consolidation. All brand-name versions of isosorbide mononitrate have been discontinued. The market is now entirely generic, meaning fewer manufacturers compete and supply disruptions hit harder.
- Manufacturing and raw material delays. Nitrate active pharmaceutical ingredients (APIs) can face sourcing challenges, especially when relying on overseas suppliers. A single disruption can ripple across multiple generic manufacturers.
- Localized inventory gaps. Even when the drug is available nationally, individual pharmacies — especially independent ones — may run out. Demand spikes, wholesaler allocation, and ordering cycles all contribute to patchy local availability.
- High demand, steady patient population. Coronary artery disease affects tens of millions of Americans, and many are older adults on fixed medication schedules. The demand for isosorbide is consistent and large — which means any supply hiccup feels outsized.
- New market entrants adding (and withdrawing) supply. In April 2026, ANI Pharmaceuticals received FDA approval and launched new isosorbide mononitrate 10 mg and 20 mg tablets — a positive sign for supply. However, the transition periods when manufacturers enter or exit the market can create temporary gaps.
Is There an Official FDA Shortage for Isosorbide in 2026?
The FDA tracks drug shortages through its Drug Shortages Database. Isosorbide mononitrate has appeared on shortage lists at various points, and Drugs.com maintains an active shortage notice page for isosorbide mononitrate tablets. The situation can change quickly — what's scarce in one region may be available in another. The key takeaway: even without an official national shortage declaration, localized gaps are common and real.
Which Forms of Isosorbide Are Most Affected?
Both isosorbide mononitrate (ISMN) and isosorbide dinitrate (ISDN) can face availability challenges, but ISMN tablets — especially the 10 mg and 20 mg immediate-release forms — have been the most frequently reported as hard to find. Extended-release forms (30 mg, 60 mg, 120 mg) sometimes have better availability at larger chain pharmacies.
Patients on the immediate-release formulation who take it twice daily (7 hours apart) are particularly vulnerable to stock disruptions, since they need consistent supply and cannot easily skip doses.
What Should You Do if Your Pharmacy Is Out of Isosorbide?
First and most importantly: do not stop taking isosorbide abruptly without talking to your doctor. Sudden discontinuation can trigger rebound angina, which is dangerous. If your pharmacy is out of stock, here's what to do:
- Ask your pharmacist to check when their next shipment arrives and whether they can order it urgently.
- Call other pharmacies in your area — availability varies widely block by block.
- Ask your doctor if a temporary bridge with nitroglycerin patches or another nitrate form is appropriate while you locate your medication.
- Use medfinder to locate pharmacies that have your specific isosorbide formulation in stock — we call pharmacies near you so you don't have to.
Why Calling Pharmacies Is So Difficult (and How to Make It Easier)
Calling around to pharmacies to check isosorbide stock is time-consuming and frustrating. Pharmacy staff are often unable to give accurate over-the-phone inventory answers, and hold times can be long. medfinder solves this by calling pharmacies on your behalf, confirming which ones can fill your specific prescription, and texting you the results. It works for isosorbide mononitrate, isosorbide dinitrate, and all formulations.
How Long Does an Isosorbide Shortage Last?
It depends on the cause. Localized inventory gaps at individual pharmacies typically resolve within days to a few weeks as wholesalers restock. Broader manufacturing disruptions can last months. The April 2026 entry of ANI Pharmaceuticals into the ISMN market should help overall supply, but patients should always keep a buffer of medication on hand and refill a few days before running out.
Are There Alternatives to Isosorbide If I Can't Get It?
There are several alternative angina medications your doctor may consider if isosorbide is unavailable for an extended period. These include beta-blockers like metoprolol, calcium channel blockers like amlodipine, and ranolazine (Ranexa). See our full guide on alternatives to isosorbide for a detailed comparison. Never switch medications on your own — always work with your cardiologist or prescriber.
Bottom Line
Isosorbide mononitrate and dinitrate availability issues in 2026 stem from a combination of generic market concentration, raw material supply chains, and uneven local pharmacy inventory. The situation is improving as new manufacturers enter the market, but patients need practical tools to find their medication when shortages hit. Don't wait until you're completely out — start looking early and use every tool available to locate your supply.
Frequently Asked Questions
Isosorbide mononitrate has experienced localized shortages in 2026. While there is no nationwide shortage declaration at this time, availability varies by pharmacy and region. ANI Pharmaceuticals launched new 10 mg and 20 mg ISMN tablets in April 2026, which should help improve supply over time.
Your pharmacy may be out of isosorbide mononitrate due to manufacturer supply disruptions, wholesaler allocation issues, or high local demand. All brand-name versions of isosorbide mononitrate have been discontinued, leaving only generics from a limited number of manufacturers — which makes supply more fragile.
No. You should never stop isosorbide mononitrate abruptly without talking to your doctor. Sudden discontinuation can trigger rebound angina, which can be dangerous. Contact your prescriber right away if you are unable to find your medication and need a short-term plan.
Yes. Isosorbide mononitrate is only available as a generic — all brand-name versions (Imdur, Monoket, ISMO) have been discontinued. Multiple generic manufacturers produce it. Generics are bioequivalent to the brand and work exactly the same way.
Both are nitrate medications used to prevent angina. Isosorbide mononitrate (ISMN) is the active metabolite of isosorbide dinitrate (ISDN). ISMN has more predictable absorption and is taken once or twice daily. ISDN requires 2–3 doses per day and has more variable bioavailability due to first-pass liver metabolism.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Isosorbide also looked for:
More about Isosorbide
29,999 have already found their meds with Medfinder.
Start your search today.





